Chromatin remodeling regulated by steroid and nuclear receptors

Cell Research

Volumn 7, Issue 2, 1997, Pages 127-142

  Wolffe, Alan P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Coactivator; Corepressor; Histone modification; Nuclear receptor; Nucleosome positioning; Steroid receptor; Transcriptional activation; Transcriptional repression

Indexed keywords

CELL RECEPTOR; STEROID RECEPTOR;

ANIMAL; CHROMATIN; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; CHROMATIN; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID;

EID: 0031308763     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/cr.1997.14     Document Type: Article

References (110)

1. O'Malley BW, Towle HG, Schwartz RJ. Regulation of gene expression in eukaryotes. Ann Rev Gent 1977; 11:239-75.
2. Lawson GM, Tsai MJ, O'Malley BW. Deoxyribonuclease I sensitivity of the non-transcribed sequences flanking the 5′ and 3′ ends of the oromucoid gene and the ovalbumin and its related X and Y genes in hen oviduct nuclei. Biochemistry 1980; 19:4403-41.
3. Lawson GM, Knoll BJ, March CJ, Woo SL, Tsai MJ, O'Malley BW. Definition of 5′ and 3′ structural boundaries of the chromatin domain containing the ovalbumin multigene family. J Biol Chem 1982; 257:1501-7.
4. Anderson JN, Vanderbilt JN, Lawson GM, Tsai MJ, O'Malley BW. Chromatin structure of the ovalbumin gene family in the chicken oviduct. Biochemistry 1983; 22:21-30.
5. Stumph WE, Baez M, Beattie WG, Tsai MJ, O'Malley BW. Characterization of deoxyribonucleic acid sequences at the 5′ and 3′ borders of the 100 kilobase pair ovalbumin gene domain. Biochemistry 1983; 22:306-15.
6. Stumph WE, Baez M, Lawson GM, Tsai MJ, O'Malley BW. Higher-order structural determinants for expression of the ovalbumin gene family. Ciba Found Symp 1983; 98:80-95.
7. Elgin SCR. The formation and function of DNasel hypersensitive sites in the process of gene activation. J Biol Chem 1988; 263:19259-62.
8. Wong J, Li Q, Levi B-Z, Shi Y-B, Wolffe AP. Structural and functional features of a specific nucleosome containing a recognition element for the thyroid hormone receptor. EMBO J 1997; (in press).
9. Burch JB, Weintraub H. Temporal order of chromatin structural changes associated with acti vation of the major chicken vitellogenin gene. Cell 1983; 33:65-76.
10. Burch JB, Evans MI, Friedman TM, O'Malley PJ. Two functional estrogen response elements are located upstream of the major chicken vitellogenin gene. Mol Cell Biol 1988; 8:1123-31.
11. Philipsen JN, Hennis BC, Ab G. In vivo footprinting of the estrogen-inducible vitellogenin II gene from chicken. Nucleic Acids Res 1988; 16:9663-76.
12. Corthesy B, Cardinaux J-R, Claret F-X, Wahli W. An NF1- like activity and a liver-specific repressor govern estrogen-regulated in vitro transcription from the Xenopus vitellogenin B1 promoter. Mol Cell Biol 1989; 9:5548-62.
13. Corthesy B, Hipskind R, Theulaz I, Wahli W. Estrogen-dependent in vitro transcription from the vitellogenin promoter in liver nuclear extracts. Science 1988; 239:1137-9.
14. Corthesy B, Leonnard P, Wahli W. Transcriptional potentiation of the vitellogenin B1 promoter by a combination of both nucleosome assembly and transcription factors: an in vitro dissection. Mol Cell Biol 1990; 10:3926-33.
15. Schild C, Claret F-X, Wahli W, Wolffe AP. A nucleosome- dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro . EMBO J 1993; 12:423-33.
16. Alevizopoulos A, Dusserre Y, Tsai-Pflulgfelder M, Von Der Weid T, Wahli W, Mermod N. A proline-rich TGF-β-responsive transcriptional activator interacts with histone H3. Genes Dev 1995; 9:3051-66.
17. Tata JR, Smith DF. Vitellogenesis: a versatile model for hormonal regulation of gene expression. Recent Prog Hormone Res 1979; 35:47-90.
18. Williams JL, Tata JR. Simultaneous analysis of conformation and transcription of A and B roups of vitellogenin genes in male and female Xenopus during primary and secondary activation by estrogen. Nucl Acids Res 1983; 11:1151-66.
19. Wolffe AP, Tata JR. Coordinate and non-coordinate estrogen-induced expression of A and B groups of vitellogenin genes in male and female Xenopus hepatocytes in culture. Eur J Biochem 1983; 130:365-72.
20. Barton MC, Shapiro DJ. Transient administration of estradiol- 17 beta establishes an autoregulatory loop permanently inducing estrogen receptor mRNA. Proc Natl Acad Sci USA 1988; 85:7119-23.
21. Burch JB, Evans, MI. Chromatin structural transitions and the phenomenon of vitellogenin gene memory in chickens. Mol Cell Biol 1986; 6:1886-93.
22. Gilbert DM, Losson R, Chambon P. Ligand dependence of estrogen receptor induced changes in chromatin structure. Nucl Acids Res 1992; 20:4525-31.
23. Pham TA, Ellist JF, Nawaz Z, McDonnell DP, Tsai MJ, O'Malley BW. Antiestrogen can establish non productive receptor complexes and alter chromatin structure at target enhancers. Proc Natl Acad Sci USA 1991; 88:3125-9.
24. Morse RH. Nucleosome disruption by transcription factor binding in yeast. Science 1993; 262:1563-6.
25. Clark LJ, O'Neill LP, Turner BM. Selective use of H4 acetylation sites in the yeast Saccharomyces cerevisiae. Biochem J 1993; 294:557-61.
26. Landsman D. Histone HI in Saccharomyces cerevisiae: a double mystery solved. Trends Biochem Sci 1996; 21:287-8.
27. Pham TA, Hwung Y-P, McDonnell DP, O'Malley BW. Transactivation functions facilitate the disruption of chromatin structure by estrogen receptor derivaties in vivo. J Biol Chem 1991; 266:18179-87.
28. Stafford GA, Morse RH. Chromatin remodeling by transcriptional activation domains in a yeast episome. J Biol Chem 1997; 272:11526-34.
29. Chiba H, Muramatsu M, Nomoto A, Kato H. Two human homologs of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucl Acids Res 1994; 22:1815-20.
30. Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searoy B, Kurokawa R, Brown M. p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 1996; 93:11540-5.
31. Zaret KS, Yamamoto KR. Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid dependent enhancer element. Cell 1984; 38:29-38.
32. Wolffe AP. Architectural transcription factors. Science 1994; 264:1100-1.
33. Wolffe AP. Nucleosome positioning and modification: chromatin structures that potentiate transcription. Trends Biochem Sci 1994; 19:240-4.
34. Archer TK, Lefebvre P, Wolford RG, Hager GL. Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 1992; 255:1573-6.
35. Archer TK, Cordingley MG, Marsaud V, Richard-Foy H, Hager GL. Steroid transactivation at a promoter organized in a specifically positioned array of nucleosomes. In Proceedings: Second International CBT Symposium on the Steroid/Thyroid Receptor Family and Gene Regulation. Springer Verlage, Berlin, 1989: pp 221-38.
36. Pina B, Barettino D, Truss M, Beato M. Structural features of a regulatory nucleosome. J Mol Biol 1990; 216:975-90.
37. Perlmann T, Wrange O. Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J 1988; 7:3073-83.
38. Archer TK, Cordingley MG, Wolford RG, Hager GL. Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol Cell Biol 1991; 11:688-98.
39. Richard-Foy H, Hager GL. Sequence- specific positioning of nucleosomes over the steroid- inducible MMTV promoter. EMBO J 1987; 6:2321-8.
40. Fragoso G, John S, Robertis S, Hager GL. Nucleosome positioning on the MMTV LTR from the frequently-biased occupancy of multiple frames. Genes Dev 1995; 9:1933-47.
41. Roberts MS, Fragoso G, Hager GL. The MMTV LTR B nucleosome adopts multiple translational and rotational positions during in vitro reconstitution. Biochemistry 1995; 34:12470-80.
42. Meersseman G, Pennings S, Bradbury EM. Mobile nucleosomes- a general behavior. EMBO J 1992; 11:2951-9.
43. Ura K, Hayes JJ, Wolffe AP. A positive role for nucleosome mobility in the transcriptional activity of chromatin templates: restriction by linker histones. EMBO J 1995; 14:3752-65.
44. Pina B, Bruggemeier U, Beato M. Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter. Cell 1990; 60:719-31.
45. Perlmann T, Wrange O. Inhibition of chromatin assembly in Xenopus cocytes correlates with derepression of the mouse mammary tumor virus promoter. Mol Cell Biol 1991; 11:5259-65.
46. Chavez S, Beato M. Nucleosome- mediated synergism between transcription factors on the mouse mammary tumor virus promoter. Proc Natl Acad Sci USA 1997; 94:2885-90.
47. Truss M, Bartsch J, Schelbert A, Hach RJG, Beato M. Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J 1995; 14:1737-51.
48. Li Q, Wrange O. Translational positioning of a nucleosomal glucocorticoid response element modulates glucocorticoid receptor affinity. Genes and Dev 1993; 7:2471-82.
49. Li Q, Wrange O. The accessibility of a glucocorticoid response element dependent on its rotational positioning. Mol Cell Biol 1995; 15:4375-84.
50. Pham TA, McDonnell DP, Tsai MJ, O'Malley BW. Modulation of progesterone receptor binding to progesterone response elements by positioned nucleosomes. Biochemistry 1992; 31:1570-8.
51. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler P. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991; 352:497-502.
52. Candau R, Chavez S, Beato M. The hormone responsive region of mouse mammary tumor virus positions a nucleosome and precludes access of nuclear factor 1 to the promoter. J Steroid Biochem Mol Biol 1996; 57:19-31.
53. Blomquist P, Li Q, Wrange O. The affinity of nuclear factor 1 for its DNA site is drastically reduced by nucleosome organization irrespective of its rotational and translational position. J Biol Chem 1996; 271:154-9.
54. Carr KD, Richard-Foy H. Glucocorticoids locally disrupt an array of positioned nucleosomes on the rat tyrosine aminotransferase promoter in hepatoma cells. Proc Natl Acad Sci USA 1990; 87:9300-4.
55. Reik A, Schutz G, Stewart AF. Glucocorticoids are required for establishment and maintenance of an alteration in chromatin structure: induction leads to a reversible disruption of nucleosomes over an enhancer. EMBO J 1991; 10:2569-76.
56. Schmid A, Fascher KD, Horz W. Nucleosome disruption at the PHO5 promoter upon PHO5 induction occurs in the absence of DNA replication. Cell 1992; 71:853-64.
57. Polach KJ, Widom J. A model cooperative binding of eukaryotic regulatory proteins to nucleosomal target sites. J Mol Biol 1996; 258:800-12.
58. Polach KJ, Widom J. Mechanism of protein access to specific DNA sequences in chromatin: a dynamic equilibrium model for gene regulation. J Mol Biol 1995; 254:130-49.
59. Adams CC, Workman JL. The binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Mol Cell Biol 1995; 15:1405-21.
60. Kurumizaka H, Wolffe AP. Sin mutations of histone H3: influence on nucleosome core structure and function. Mol Cell Biol 1997; (in press).
61. Caron F, Thomas JO. Exchange of histone H1 between segments of chromatin. J Mol Biol 1981; 146:513-37.
62. Louters L, Chalkley R. Exchange of histones H1, H2A and H2B in vivo. Biochemistry 1985; 24:3080-5.
63. Pennings S, Meersseman G, Bradbury EM. Mobility of positioned nucleosomes on 5S rDNA. J Mol Biol 1991; 220:101-10.
64. Chipev CC, Wolffe AP. Chromosomal organization of Xenopus laevis oocyte and somatic 5S rRNA genes in vivo. Mol Cell Biol 1992; 12:45-55.
65. Varga-Weisz PD, Wilm M, Boute E, Dumas K, Mann M, Becker PB. Chromatin remodeling factor CHRAC contains the ATPses ISWI and topoisomerase II. Nature 1997; 388:598-602.
66. Pazin MJ, Kamakaka RT, Kadonaga JT. ATP- dependent nucleosome reconfiguration and transcriptional activation from preassembled chromatin templates. Science 1994; 266:2007-11.
67. Hayes JJ, Clark DJ, Wolffe AP. Histone contributions to the structure of DNA in the nucleosome Proc. Natl Acad Sci USA 1991; 88:6829-33.
68. Yoshinaga SK, Peterson SL, Herskowitz I, Yamamoto KR. Roles of SWI1, SWI2 and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 1992; 258:1598-604.
69. Muchardt C, Yaniv M. A human homolog of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 1993; 12:4279-90.
70. Bresnick EH, Bustin M, Marsaud V, Richard-Foy H, Hager GL. The transcriptionally- active MMTV promoter is depleted of HI. Nucl Acids Res 1992; 20:273-8.
71. Lee HH, Archer TK. Nucleosome-mediated disruption of transcription factor-chromatin initiation complexes at the mouse mammary tumor virus long terminal repeat in vivo. Mol Cell Biol 1994; 14:32-41.
72. Bartsch J, Truss M, Bode J, Beato M. Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. Proc Natl Acad Sci USA 1996; 93:10741-6.
73. Perlman AJ, Stanley F, Samuels HH. Thyroid hormone nuclear receptor: evidence for multimeric organization in chromatin. J Biol Chem 1982; 257:930-8.
74. Samuels HH, Perlman AJ, Raaka BM, Stanley F. Organization of the thyroid hormone receptor in chromatin. Rec Prog Hormone Res 1982; 38:557-99.
75. Glass CK, Lipkin SM, Devary OV, Rosenfeld MG. Positive and negative regulation of gene transcription by a retinoic acid- thyroid hormone receptor heterodimer. Cell 1989; 59:697-708.
76. Leblanc BP, Stunnenberg HG. 9- cis retinoic acid signaling: Changing partners causes some excitement. Genes Dev 1995; 9:1811-6.
77. Li C, Schwabe JWR, Banayo E, Evans RM. Co- expression of nuclear receptor partners increases their solubility and biological activities. Proc Natl Acad Sci USA 1997; (in press).
78. Fondell JD, Roy AL, Roeder RG. Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes and Devel 1993; 7:1400-10.
79. Baniahmad A, Ha I, Reinberg D, Tsai SY, Tsai MJ, O'Malley BW. Interaction of a receptor β with transcription factor TFIIB may mediate target gene activation and derepression by thyroid hormone. Proc Natl Acad Sci USA 1993; 90:8832-6.
80. Le Douarin B, Zechel C, Garnier J-M, Lutz Y, Tora L, Pierrat B, et al. The N-terminal part of TIF1, a putative mediator of the ligand- dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995; 14:2020-33.
81. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H. A 160 KDa transcription mediator for the ligand-dependent activation function AF- 2 of nuclear receptors. EMBO J 1996; 15:3667-75.
82. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokama R, Gloss B, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996; 85:403-14.
83. Fondell JD, Ge H, Roeder RG. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci USA 1996; 93:8329-33.
84. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995; 377:397-404.
85. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptor. Nature 1995; 377:454-7.
86. Chen JD, Umesono K, Evans RM. SMRT isoforms mediate repression and antirepression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 1996; 93:7567-71.
87. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Juguilon H, Montminy M, Evans, RM. Mediation of nuclear receptor signalling by CBP/p300. Nature 1996; 383:99-103.
88. Yang X-J, Ogryzko VV, Nishikawa J-I, Howard B, Nakatani, Y. A p300/CBP-associated factor that competes with the adenoviral E1A oncoprotein. Nature 1996; 382:319-24.
89. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996; 87:953-9.
90. Onate SA, Tsai SY, Tsai M- J, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270:1354-7.
91. Alland L, Muhle R, Hou Jr H, Poles J, Chin L, Schreiber-Agus N, et al. Role of NCoR and histone deacetylase in Sin3- mediated transcriptional and oncogenic repression. Nature 1997; 387:49-55.
92. Heinzel T, Laviusky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia JT, et al. N- CoR, mSIN3, and histone deacetylase in a complex required for repression by nuclear receptors and Mad. Nature 1997; 387:43-8.
93. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 1997; 89:373-80.
94. Hebbes TR, Thorne AW, Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J 1988; 7:1395-402.
95. Hebbes TR, Thorne AW, Clayton AL, Crane- Robinson C. Histone acetylation and globin gene switching. Nucl Acids Res 1992; 20:1017-22.
96. Hebbes TR, Clayton AL, Thorne AW, Crane-Robinson C. Core histone hyperacetylation comaps with generalized DNase I sensitivity in the chicken β- globin chromosomal domain. EMBO J 1994; 13:1823-30.
97. Tazi J, Bird A. Alternative chromatin structure at CpG islands. Cell 1990; 60:902-20.
98. Lee DY, Hayes JJ, Pruss D, WolfFe AP. A positive role for histone acetylation in transcription factor binding to nucleosomal DNA. Cell 1993; 72:73-84.
99. Ura K, Kurumizaka H, Dimitrov S, Almouzni G, Wolffe AP. Histone acetylation: influence on transcription by RNA polymerase, nucleosome mobility and positioning, and linker histone dependent transcriptional repression. EMBO J 1997; 16:2096-2107.
100. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY, Allis CD. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 1996; 84:843-51.
101. Janknecht R, Hunter T. A growing coactivator network. Nature 1996; 383:22-3.
102. Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to a yeast transcriptional regulator Rpd3. Science 1996; 272:408-11.
103. Yang WM, Inouye C, Zeng Y, Bearss D, Soto E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 1996; 93:12845-50.
104. Shi Y, Seto E, Chang L-S, Shenk T. Transcriptional repression by YY1, a human GL1- Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 1991; 67:377-88.
105. Shrivastava A, Calame K. An analysis of genes regulated by the multi-functional transcriptional regulatory Yin yang 1. Nucl Acids Res 1994; 22:5151-5.
106. Ayer DE, Lawrence QA, Eisenman RN. Mad- Max transcriptional repression is mediated by termary complex formation with mammalian homologs of yeast represser Sin3. Cell 1995; 80:767-76.
107. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, et al. Histone deacetylase associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 1997; 89:349-56.
108. Yoshida M, Kijima M, Akita M, Beppu T, Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by Trichostatin A J. Biol Chem 1990; 265:17174-9.
109. Wong J, Shi Y-B, Wolffe AP. A role for nucleosome assembly in both silencing and activation of the Xenopus TRβ A gene by the thyroid hormone receptor. Genes Dev 1995; 9:2696-711.
110. Wong J, Shi Y-B, Wolffe AP. Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone regulated chromatin disruption is not sufficient for transcriptional activation. EMBO J 1997; 16:3158-71.